Last reviewed · How we verify

Periarticular Injection (PAI) — Competitive Intelligence Brief

Periarticular Injection (PAI) (Periarticular Injection (PAI)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Orthopedic Surgery / Pain Management.

marketed Orthopedic Surgery / Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Periarticular Injection (PAI) (Periarticular Injection (PAI)) — Hospital for Special Surgery, New York. Periarticular injection delivers therapeutic agents directly into the tissue surrounding a joint to reduce inflammation and pain during or after orthopedic surgery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Periarticular Injection (PAI) TARGET Periarticular Injection (PAI) Hospital for Special Surgery, New York marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Periarticular Injection (PAI) — Competitive Intelligence Brief. https://druglandscape.com/ci/periarticular-injection-pai. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: